{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,16]],"date-time":"2026-02-16T08:16:07Z","timestamp":1771229767226,"version":"3.50.1"},"reference-count":45,"publisher":"Oxford University Press (OUP)","issue":"9","license":[{"start":{"date-parts":[[2012,9,1]],"date-time":"2012-09-01T00:00:00Z","timestamp":1346457600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2012,9,1]]},"abstract":"<jats:title>ABSTRACT<\/jats:title><jats:sec><jats:title>Introduction<\/jats:title><jats:p>Lower urinary tract symptoms secondary to benign prostatic hyperplasia (BPH-LUTSs) may be associated with erectile dysfunction (ED). Phosphodiesterase type 5 (PDE5) inhibitors used for treating ED have shown clinical benefit in patients with LUTS but their actions in human LUT tissues are not well defined.<\/jats:p><\/jats:sec><jats:sec><jats:title>Aim<\/jats:title><jats:p>To determine the effects of the long-acting PDE5 inhibitor, tadalafil, on smooth muscle tone in human prostate and bladder neck as well as to evaluate the influence of tadalafil on the efficacy of the \u03b1-adrenergic receptor antagonist, tamsulosin, in inhibiting contractile responses in these tissues.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>Strips of human peripheral prostate (HPP), human internal prostate (HIP), and human bladder neck (HBN) were obtained from organ donors and patients with BPH. The strips were then disposed in organ baths to evaluate nitric oxide\/cyclic guanosine monophosphate (cGMP)-mediated relaxation and cGMP kinetics in HPP and HIP, and electrical field stimulation (EFS)-induced neurogenic contractions in HPP and HBN.<\/jats:p><\/jats:sec><jats:sec><jats:title>Main Outcome Measures<\/jats:title><jats:p>Tadalafil-induced effects on sodium nitroprusside (SNP)-induced relaxation and cGMP accumulation in HPP and HIP and influence of tadalafil and tamsulosin on EFS-induced contractions of HPP and HBN.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>SNP-induced relaxation of HPP and HIP was significantly potentiated by tadalafil (30\u201360 nM). SNP-induced cGMP accumulation in HPP and HIP was enhanced by tadalafil (30\u201360 nM), but significant difference was only obtained in HPP. EFS-induced contractions sensitive to tetrodotoxin in HPP were significantly inhibited by tadalafil (30 nM) but not by tamsulosin (0.01\u2013100 nM) or vehicle. Further inhibition of neurogenic responses in HPP was achieved by combining tadalafil and tamsulosin treatments. Tamsulosin, but not tadalafil, significantly reduced EFS-induced contractions in HBN, but the coadministration of both therapies resulted in additional inhibition of contractions.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>While tadalafil enhances cGMP accumulation and potentiates prostate relaxation, tadalafil combined with tamsulosin results in enhanced inhibition of neurogenic contractions of HPP and HBN.<\/jats:p><\/jats:sec>","DOI":"10.1111\/j.1743-6109.2012.02821.x","type":"journal-article","created":{"date-parts":[[2012,7,3]],"date-time":"2012-07-03T19:11:24Z","timestamp":1341342684000},"page":"2293-2306","source":"Crossref","is-referenced-by-count":48,"title":["Tadalafil Enhances the Inhibitory Effects of Tamsulosin on Neurogenic Contractions of Human Prostate and Bladder Neck"],"prefix":"10.1093","volume":"9","author":[{"given":"Javier","family":"Angulo","sequence":"first","affiliation":[{"name":"Servicio de Histolog\u00eda, Departamento de Investigaci\u00f3n, Hospital Universitario Ram\u00f3n y Cajal , Madrid , Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pedro","family":"Cuevas","sequence":"additional","affiliation":[{"name":"Servicio de Histolog\u00eda, Departamento de Investigaci\u00f3n, Hospital Universitario Ram\u00f3n y Cajal , Madrid , Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Argentina","family":"Fern\u00e1ndez","sequence":"additional","affiliation":[{"name":"Servicio de Histolog\u00eda, Departamento de Investigaci\u00f3n, Hospital Universitario Ram\u00f3n y Cajal , Madrid , Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jos\u00e9 M.","family":"La Fuente","sequence":"additional","affiliation":[{"name":"Servi\u00e7o de Urologia, Hospital Santo Antonio , Porto , Portugal"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antonio","family":"Allona","sequence":"additional","affiliation":[{"name":"Servicio de Urolog\u00eda, Hospital Ruber Internacional , Madrid , Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ignacio","family":"Moncada","sequence":"additional","affiliation":[{"name":"Servicio de Urolog\u00eda, Hospital La Zarzuela , Madrid , Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"I\u00f1igo","family":"S\u00e1enz de Tejada","sequence":"additional","affiliation":[{"name":"Servicio de Histolog\u00eda, Departamento de Investigaci\u00f3n, Hospital Universitario Ram\u00f3n y Cajal , Madrid , Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2012,9,1]]},"reference":[{"key":"2024032600391421700_bb0010","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1016\/j.eururo.2003.08.015","article-title":"Lower urinary tract symptoms and male sexual dysfunction: The multinational survey of the aging male (MSAM-7)","volume":"44","author":"Rosen","year":"2003","journal-title":"Eur Urol"},{"key":"2024032600391421700_bb0015","article-title":"Tadalafil for the treatment of lower urinary tract symptoms secondary to benign prostatic hyperplasia: Pathophysiology and mechanism(s) of action","author":"Andersson","year":"2010","journal-title":"Neurourol Urodyn"},{"key":"2024032600391421700_bb0020","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.1016\/j.juro.2006.11.037","article-title":"Tadalafil relieves lower urinary tract symptoms secondary to benign prostatic hyperplasia","volume":"177","author":"McVary","year":"2007","journal-title":"J Urol"},{"key":"2024032600391421700_bb0025","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1016\/j.juro.2008.06.079","article-title":"Tadalafil administered once daily for lower urinary tract symptoms secondary to benign prostatic hyperplasia: A dose finding study","volume":"180","author":"Roehrborn","year":"2008","journal-title":"J Urol"},{"key":"2024032600391421700_bb0030","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1111\/j.1464-410X.2009.08822.x","article-title":"Changes in peak urinary flow and voiding efficiency in men with signs and symptoms of benign prostatic hyperplasia during once daily tadalafil treatment","volume":"105","author":"Roehrborn","year":"2010","journal-title":"BJU Int"},{"key":"2024032600391421700_bb0035","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1016\/j.eururo.2005.12.050","article-title":"Immunohistochemical distribution of cAMP- and cGMP-phosphodiesterase (PDE) isoenzymes in the human prostate","volume":"49","author":"\u00dcckert","year":"2006","journal-title":"Eur Urol"},{"key":"2024032600391421700_bb0040","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1111\/j.1743-6109.2009.01511.x","article-title":"Characterization of phosphodiesterase type 5 expression and functional activity in the human male lower urinary tract","volume":"7","author":"Fibbi","year":"2010","journal-title":"J Sex Med"},{"key":"2024032600391421700_bb0045","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1210\/en.2006-1079","article-title":"Characterization and functional role of androgen-dependent PDE5 activity in the bladder","volume":"148","author":"Filippi","year":"2007","journal-title":"Endocrinology"},{"key":"2024032600391421700_bb0050","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1007\/s00345-008-0303-y","article-title":"The nitric oxide pathway in the human prostate: Clinical implications in men with lower urinary tract symptoms","volume":"26","author":"Kedia","year":"2008","journal-title":"World J Urol"},{"key":"2024032600391421700_bb0055","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/S0165-1838(96)00139-7","article-title":"Heme oxygenase and NO-synthase in the human prostate\u2014Relation to adrenergic, cholinergic and peptide-containing nerves","volume":"63","author":"Hedlund","year":"1997","journal-title":"J Auton Nerv Syst"},{"key":"2024032600391421700_bb0060","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1016\/S0090-4295(99)80012-0","article-title":"Characterization and localization of nitric oxide synthase in the human prostate","volume":"45","author":"Burnett","year":"1995","journal-title":"Urology"},{"key":"2024032600391421700_bb0065","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/(SICI)1097-0045(19970915)33:1<1::AID-PROS1>3.0.CO;2-P","article-title":"Distribution of nitric oxide synthase implies a regulation of circulation, smooth muscle tone, and secretory function in the human prostate by nitric oxide","volume":"33","author":"Bloch","year":"1997","journal-title":"Prostate"},{"key":"2024032600391421700_bb0070","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1046\/j.1469-7580.1997.19010125.x","article-title":"A double-label immunohistochemical study of intramural ganglia from the human male urinary bladder neck","volume":"190","author":"Dixon","year":"1997","journal-title":"J Anat"},{"key":"2024032600391421700_bb0075","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1124\/pr.56.4.4","article-title":"Pharmacology of the lower urinary tract: Basis for current and future treatments of urinary incontinence","volume":"56","author":"Andersson","year":"2004","journal-title":"Pharmacol Rev"},{"key":"2024032600391421700_bb0080","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1111\/j.1743-6109.2009.01587.x","article-title":"Diabetes exacerbates the functional deficiency of NO\/cGMP pathway associated with erectile dysfunction in human corpus cavernosum and penile arteries","volume":"7","author":"Angulo","year":"2010","journal-title":"J Sex Med"},{"key":"2024032600391421700_bb0085","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1006\/bbrc.1998.8769","article-title":"Molecular cloning and expression of human cGMP-binding cGMP-specific phosphodiesterase (PDE5)","volume":"247","author":"Stacey","year":"1998","journal-title":"Biochem Biophys Res Commun"},{"key":"2024032600391421700_bb0090","doi-asserted-by":"crossref","first-page":"2746","DOI":"10.1111\/j.1743-6109.2011.02416.x","article-title":"Phosphodiesterase type 5 expression in human and rat lower urinary tract tissues and the effect of tadalafil on prostate gland oxygenation in spontaneously hypertensive rats","volume":"8","author":"Morelli","year":"2011","journal-title":"J Sex Med"},{"key":"2024032600391421700_bb0095","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1016\/j.urology.2007.10.051","article-title":"Effects of phosphodiesterase inhibitors on tension induced by norepinephrine and accumulation of cyclic nucleotides in isolated human prostatic tissue","volume":"71","author":"\u00dcckert","year":"2008","journal-title":"Urology"},{"key":"2024032600391421700_bb0100","doi-asserted-by":"crossref","first-page":"E243","DOI":"10.1152\/ajpendo.00458.2011","article-title":"Testosterone regulates smooth muscle contractile pathways in the rat prostate: Emphasis on PDE5 signaling","volume":"302","author":"Zhang","year":"2012","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"2024032600391421700_bb0105","doi-asserted-by":"crossref","first-page":"2253","DOI":"10.1210\/en.2003-1699","article-title":"Androgens regulate phosphodiesterase type 5 expression and functional activity in corpora cavernosa","volume":"145","author":"Morelli","year":"2004","journal-title":"Endocrinology"},{"key":"2024032600391421700_bb0110","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1097\/01.ju.0000097026.43866.cc","article-title":"Alpha1-adrenergic receptors and their inhibitors in lower urinary tract symptoms and benign prostatic hyperplasia","volume":"171","author":"Roehrborn","year":"2004","journal-title":"J Urol"},{"key":"2024032600391421700_bb0115","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1111\/j.1474-8673.1996.tb00352.x","article-title":"Drugs for treatment of benign prostatic hyperplasia: Affinity comparison at cloned \u03b11-adrenoceptor subtypes and in human prostate","volume":"16","author":"Michel","year":"1996","journal-title":"J Auton Pharmacol"},{"key":"2024032600391421700_bb0120","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1016\/S0022-5347(17)38780-3","article-title":"Autoradiographic analysis of alpha-adrenoceptors and muscarinic cholinergic receptors in the hyperplastic human prostate","volume":"142","author":"James","year":"1989","journal-title":"J Urol"},{"key":"2024032600391421700_bb0125","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1016\/S0022-5347(17)47714-7","article-title":"Alpha-adrenoceptors and muscarinic receptors in the isolated human prostate","volume":"134","author":"Hedlund","year":"1985","journal-title":"J Urol"},{"key":"2024032600391421700_bb0130","doi-asserted-by":"crossref","first-page":"S88","DOI":"10.1038\/sj.bjp.0706619","article-title":"\u03b11-, \u03b12- and \u03b2-adrenoceptors in the urinary bladder, urethra and prostate","volume":"147","author":"Michel","year":"2006","journal-title":"Br J Pharmacol"},{"key":"2024032600391421700_bb0135","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1111\/j.1743-6109.2008.01138.x","article-title":"Combination of doxazosin and sildenafil exerts an additive relaxing effect compared with each compound alone on human cavernosal and prostatic tissue","volume":"6","author":"Oger","year":"2009","journal-title":"J Sex Med"},{"key":"2024032600391421700_bb0140","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1016\/j.eururo.2009.04.039","article-title":"Combination of alfuzosin and tadalafil exerts an additive relaxant effect on human detrusor and prostatic tissues in vitro","volume":"57","author":"Oger","year":"2010","journal-title":"Eur Urol"},{"key":"2024032600391421700_bb0145","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1111\/j.1365-2125.2005.02553.x","article-title":"Tadalafil pharmacokinetics in healthy subjects","volume":"61","author":"Forgue","year":"2006","journal-title":"Br J Clin Pharmacol"},{"key":"2024032600391421700_bb0150","author":"Eli Lilly & Company","year":"2011","journal-title":"Cialis: EPAR-Product information"},{"key":"2024032600391421700_bb0155","doi-asserted-by":"crossref","first-page":"2489","DOI":"10.1016\/j.clinthera.2009.11.024","article-title":"Silodosin: A selective \u03b11A-adrenergic receptor antagonist for the treatment of benign prostatic hyperplasia","volume":"31","author":"Schilit","year":"2009","journal-title":"Clin Ther"},{"key":"2024032600391421700_bb0160","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1016\/S0026-895X(25)10243-5","article-title":"KMD-3213, a novel, potent, alpha 1a-adrenoceptor-selective antagonist: Characterization using recombinant human alpha 1-adrenoceptors and native tissues","volume":"48","author":"Shibata","year":"1995","journal-title":"Mol Pharmacol"},{"key":"2024032600391421700_bb0165","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1016\/j.eururo.2010.07.026","article-title":"Nitric oxide\/cyclic guanosine monophosphate signaling mediates an inhibitory action on sensory pathways of the micturition reflex in the rat","volume":"58","author":"Caremel","year":"2010","journal-title":"Eur Urol"},{"key":"2024032600391421700_bb0170","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1016\/j.eururo.2010.10.037","article-title":"Vardenafil decreases bladder afferent nerve activity in unanesthetized, decerebrate, spinal cord-injured rats","volume":"59","author":"Behr-Roussel","year":"2011","journal-title":"Eur Urol"},{"key":"2024032600391421700_bb0175","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/S0014-2999(98)00566-4","article-title":"The possible effect of nitric oxide on relaxation and noradrenaline release in the isolated rabbit urethra","volume":"357","author":"Yoshida","year":"1998","journal-title":"Eur J Pharmacol"},{"key":"2024032600391421700_bb0180","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/S0014-2999(00)00333-2","article-title":"Prejunctional alpha-adrenoceptors regulate nitrergic neurotransmission in the rabbit urethra","volume":"400","author":"Seshita","year":"2000","journal-title":"Eur J Pharmacol"},{"key":"2024032600391421700_bb0185","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1016\/j.ejphar.2010.10.052","article-title":"Thromboxane A2 induces contraction of human prostate smooth muscle by Rho kinase- and calmodulin-dependent mechanisms","volume":"650","author":"Strittmatter","year":"2011","journal-title":"Eur J Pharmacol"},{"key":"2024032600391421700_bb0190","doi-asserted-by":"crossref","first-page":"1148","DOI":"10.1124\/jpet.103.063735","article-title":"Signal transduction underlying carbachol-induced contraction of human urinary bladder","volume":"309","author":"Schneider","year":"2004","journal-title":"J Pharmacol Exp Ther"},{"key":"2024032600391421700_bb0195","doi-asserted-by":"crossref","first-page":"1594","DOI":"10.1111\/j.1743-6109.2009.01249.x","article-title":"Vardenafil modulates bladder contractility through cGMP-mediated inhibition of RhoA\/Rho kinase signaling pathway in spontaneously hypertensive rats","volume":"6","author":"Morelli","year":"2009","journal-title":"J Sex Med"},{"key":"2024032600391421700_bb0200","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1016\/S0090-4295(99)80013-2","article-title":"Effects of nitric oxide on human and canine prostates","volume":"45","author":"Takeda","year":"1995","journal-title":"Urology"},{"key":"2024032600391421700_bb0205","doi-asserted-by":"crossref","first-page":"2170","DOI":"10.1111\/j.1743-6109.2008.00940.x","article-title":"Comparative efficacy of tamsulosin vs. tamsulosin plus tadalafil in the treatment of LUTS\/BPH. Pilot study","volume":"5","author":"Bechara","year":"2008","journal-title":"J Sex Med"},{"key":"2024032600391421700_bb0210","doi-asserted-by":"crossref","first-page":"1717","DOI":"10.1016\/j.eururo.2007.01.033","article-title":"Combination of alfuzosin and sildenafil is superior to monotherapy in treating lower urinary tract symptoms and erectile dysfunction","volume":"51","author":"Kaplan","year":"2007","journal-title":"Eur Urol"},{"key":"2024032600391421700_bb0215","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1038\/ijir.2009.2","article-title":"Safety and efficacy of the simultaneous administration of udenafil and an alpha-blocker in men with erectile dysfunction concomitant with BPH\/LUTS","volume":"21","author":"Chung","year":"2009","journal-title":"Int J Impot Res"},{"key":"2024032600391421700_bb0220","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1007\/s00345-009-0484-z","article-title":"Sildenafil citrate and tamsulosin combination is not superior to monotherapy in treating lower urinary tract symptoms and erectile dysfunction","volume":"28","author":"Tuncel","year":"2010","journal-title":"World J Urol"},{"key":"2024032600391421700_bb0225","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1111\/j.1439-0272.2011.01268.x","article-title":"Efficacy of alfuzosin and sildenafil combination in male patients with lower urinary tract symptoms","volume":"44","author":"Ozt\u00fcrk","year":"2011","journal-title":"Andrologia"},{"key":"2024032600391421700_bb0230","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1016\/j.eururo.2011.06.037","article-title":"Critical analysis of the relationship between sexual dysfunctions and lower urinary tract symptoms due to benign prostatic hyperplasia","volume":"60","author":"Gacci","year":"2011","journal-title":"Eur Urol"}],"container-title":["The Journal of Sexual Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1743609515340972?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1743609515340972?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/academic.oup.com\/jsm\/article-pdf\/9\/9\/2293\/47770827\/jsm_9_9_2293.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jsm\/article-pdf\/9\/9\/2293\/47770827\/jsm_9_9_2293.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,3]],"date-time":"2025-04-03T04:27:15Z","timestamp":1743654435000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jsm\/article\/9\/9\/2293\/6886962"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,9,1]]},"references-count":45,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2012,9,1]]},"published-print":{"date-parts":[[2012,9,1]]}},"URL":"https:\/\/doi.org\/10.1111\/j.1743-6109.2012.02821.x","relation":{},"ISSN":["1743-6109","1743-6095"],"issn-type":[{"value":"1743-6109","type":"electronic"},{"value":"1743-6095","type":"print"}],"subject":[],"published-other":{"date-parts":[[2012,9]]},"published":{"date-parts":[[2012,9,1]]}}}